Celldex Therapeutics Inc
NASDAQ: CLDX
$41.24
+$0.08 (+0.2%)
Closing Price on September 20, 2024
CLDX Articles
New drug innovations are affecting the way that physicians treat such debilitating and deadly diseases as cancer. In a new research report, Jefferies presents the top drug innovations that investors...
Published:
Five years ago, many investors had thrown in the towel. The S&P 500 hit an ominous intraday low of 666 and closed at 676.53. The world was coming to an end, and the last place anybody wanted to...
Published:
Last Updated:
The biotech and specialty pharmaceutical groups got hit hard Thursday for a variety of reasons. The largest of which the analysts at Jefferies believe, is commentary within Washington's new budget...
Published:
The new year is well under way and the major firms on Wall Street are all presenting their best stock ideas for 2014. The team at Cantor Fitzgerald is no exception.
Published:
The team at Oppenheimer has a list of biotech stocks to buy that feature catalysts that could be game changers. They all have 50% or higher upside to the firm's price target.
Published:
For the very first time in their long and storied history, Cantor Fitzgerald has come out with a list outlining its top stock picks for the year. Long respected as a premier fixed income trading firm...
Published:
Last Updated:
We are now just about two weeks away from the king of biotech and pharma events in cancer treatments. The 2012 annual meeting of the American Society of Clinical Oncology (ASCO) is set to take...
Published:
Last Updated:
Index changes are generally speaking a fairly routine event. They can also create underlying moves in the companies added and deleted from them as money management firms often buy and sell shares,...
Published:
Last Updated:
It is now getting close to the middle of May, and that means one thing for biotech investors. The king of biotech and pharma events is about to take place. The 2012 annual meeting of the American...
Published:
Last Updated:
Active traders and day traders have many stocks to choose from this Wednesday morning. We are tracking news and moves in shares of Celldex Therapeutics (NASDAQ: CLDX), Dell Inc. (NASDAQ:...
Published:
Active traders and day traders have many stocks to choose from this Monday morning. We are tracking news and moves in shares of Affymax, Inc. (NASDAQ: AFFY), Celldex Therapeutics, Inc. (NASDAQ:...
Published:
Last Updated:
Active traders and day traders have many stocks to choose from this morning. We are tracking moves in Celldex Therapeutics, Inc. (NASDAQ: CLDX), Gymboree Corp. (NASDAQ: GYMB), Geron Corporation...
Published:
Last Updated:
Many stocks are on the move this Friday morning. Active traders and day traders are likely to be watching the moves seen in Anadarko Petroleum Corporation (NYSE: APC), Brocade Communications...
Published:
Last Updated:
Today’s edition of the BioHealth Business Daily is going to be very cancer-dominated due to the American Society of Clinical Oncology (ASCO) 2010 meeting that started this last weekend. There are...
Published:
Last Updated:
We have many movers in the after-hours session. Stocks on the move are Brocade Communications Systems, Inc. (NASDAQ: BRCD), Celldex Therapeutics, Inc. (NASDAQ: CLDX), Dell Inc. (NASDAQ: DELL), Foot...
Published:
Last Updated: